News
Number 3: Sarfaraz K. Niazi, PhD, asserts that India's recently revised 2025 biosimilar guidelines represent a significant and rational step towards global regulatory alignment by deemphasizing animal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback